Esn Cleer
ESN Cleer is committed to transforming the way we combat specific segments of Cardiomyopathy with its focus on repurposed drugs of orphan indications (rare diseases without specific drug treatments). Such detrimental diseases are some of the most significant causes of Heart Failure—an ailment that heavily impact on a large spectrum of the CVD population. Such diseases or syndromes carry a high mortality risk, but it also profoundly degrades the quality of life for those affected, thus underlining the importance of ESN Cleer's mission.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Esn Cleer
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- GD
Gustav de Bruin
Chief Operating Officer, R & d Program Director · Other
EmailPhone - ED
Elaine de Bruin
Investor Relations · General Business & Management
EmailPhone - LD
Leopoldt de Bruin
Founder, Managing Director · General Business & Management
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Esn Cleer
3 distinct titles indexed · top 3 shown.
- 1chief operating officer, r & d program director
- 1founder, managing director
- 1investor relations
Sign up to unlock all 3 contacts at Esn Cleer
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Esn Cleer
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.